September 24, 2025
Kentucky & Ohio Open Public Draft/Revised LCD Discussion Meeting: October 28, 2025
CGS will host an Open Meeting for comments from providers and the general public related to the development or revision of Medicare Jurisdiction 15 Local Coverage Determinations (LCDs).
| Date | Wednesday, October 28, 2025 |
| Time | 4 - 5:30 pm ET (3 – 4:30 pm CT) |
| Location | Microsoft Teams; please register |
NOTE: This is an Open Meeting to discuss specific draft or revisions to current LCDs, not a Contractor Advisory Committee (CAC) meeting.
Draft LCD(s) for discussion include:
- DL40261/DA60296 – Peripheral Nerve Block Procedures (will replace L35249 – Nerve Blocks for Peripheral Neuropathy)
- DL33952/DA60292 – Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices (will replace L33952 – Cardiac Event Detection)
- DL40232/DA60250 – Total Joint Arthroplasty
- DL40224/DA60245 – Automated Detection and Quantification of Brain MRIs
- DL40199/DA60215 – Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
- DL40226/DA59919 – MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer
- DL39938/DA60294 – MolDX: Genetic Testing for Hereditary Thrombophilia
Proposed LCDs not released to final: Kentucky
; Ohio![]()
Interested parties who wish to make presentations related to a draft LCD must submit a written request to CMD.Inquiry@cgsadmin.com no later than 10.21.2025. Include the following information:
- Presenter's name, address, telephone number, and e-mail
- Organization name, address, telephone number, and e-mail
- Name of draft LCD
- Copy of the presentation(s)
- Completed Conflict of Interest (COI) Form
- DL40261/DA60296 – Peripheral Nerve Block Procedures

- DL33952/DA60292 – Temporary Nontherapeutic Ambulatory Cardiac Monitoring Devices

- DL40232/DA60250 – Total Joint Arthroplasty

- DL40224/DA60245 – Automated Detection and Quantification of Brain MRIs

- DL40199/DA60215 – Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Metabolic Dysfunction-Associated Steatohepatitis (MASH)

- DL40226/DA59919 – MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer

- DL39938/DA60294 – MolDX: Genetic Testing for Hereditary Thrombophilia

- DL40261/DA60296 – Peripheral Nerve Block Procedures
You must attach the presentation and COI form to your request(s). Each presenter is allowed equal time based on the number of requests received. We will email each presenter's time allocation by October 24, 2025.
Future Meeting(s)
- February 17, 2026
- June 9, 2026
- October 27, 2026

